awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36546004-C97AD479-0443-4F63-B52D-4B34151CDC5A
Q36546004-C97AD479-0443-4F63-B52D-4B34151CDC5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36546004-C97AD479-0443-4F63-B52D-4B34151CDC5A
Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.
P2860
Q36546004-C97AD479-0443-4F63-B52D-4B34151CDC5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36546004-C97AD479-0443-4F63-B52D-4B34151CDC5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e0d0ee5094a84528065040478bc55d90ecb0341
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).